Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

CRP polymorphisms and progression of chronic kidney disease in African Americans.

Hung AM, Crawford DC, Griffin MR, Brown-Gentry K, Lipkowitz MS, Siew ED, Cavanaugh K, Lewis JB, Ikizler TA; AASK Study Group.

Clin J Am Soc Nephrol. 2010 Jan;5(1):24-33. doi: 10.2215/CJN.01900309. Epub 2009 Dec 3.

2.

CRP polymorphisms and chronic kidney disease in the third national health and nutrition examination survey.

Hung AM, Ikizler TA, Griffin MR, Glenn K, Greevy RA, Grijalva CG, Siew ED, Crawford DC.

BMC Med Genet. 2011 May 11;12:65. doi: 10.1186/1471-2350-12-65.

3.

Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey.

Crawford DC, Sanders CL, Qin X, Smith JD, Shephard C, Wong M, Witrak L, Rieder MJ, Nickerson DA.

Circulation. 2006 Dec 5;114(23):2458-65. Epub 2006 Nov 13.

4.

Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.

Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda JP, Cushman M, Bis JC, Zeng D, Lin D, Kuller LH, Nickerson DA, Psaty BM, Tracy RP, Reiner AP.

JAMA. 2006 Dec 13;296(22):2703-11.

PMID:
17164456
5.

Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.

Appel LJ, Wright JT Jr, Greene T, Kusek JW, Lewis JB, Wang X, Lipkowitz MS, Norris KC, Bakris GL, Rahman M, Contreras G, Rostand SG, Kopple JD, Gabbai FB, Schulman GI, Gassman JJ, Charleston J, Agodoa LY; African American Study of Kidney Disease and Hypertension Collaborative Research Group.

Arch Intern Med. 2008 Apr 28;168(8):832-9. doi: 10.1001/archinte.168.8.832.

6.

Interactions between C-reactive protein genotypes with markers of nutritional status in relation to inflammation.

Nienaber-Rousseau C, Swanepoel B, Dolman RC, Pieters M, Conradie KR, Towers GW.

Nutrients. 2014 Nov 11;6(11):5034-50. doi: 10.3390/nu6115034.

7.

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group.

JAMA. 2002 Nov 20;288(19):2421-31. Erratum in: JAMA. 2006 Jun 21;295(23):2726.

PMID:
12435255
8.

Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD.

Erickson KF, Lea J, McClellan WM.

Clin J Am Soc Nephrol. 2013 Jan;8(1):75-81. doi: 10.2215/CJN.03340412. Epub 2012 Oct 18.

9.

Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study.

Wong CS, Pierce CB, Cole SR, Warady BA, Mak RH, Benador NM, Kaskel F, Furth SL, Schwartz GJ; CKiD Investigators.

Clin J Am Soc Nephrol. 2009 Apr;4(4):812-9. doi: 10.2215/CJN.01780408. Epub 2009 Mar 18.

10.

Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the atherosclerosis risk in communities study.

Hsu CC, Bray MS, Kao WH, Pankow JS, Boerwinkle E, Coresh J.

J Am Soc Nephrol. 2006 Feb;17(2):504-12. Epub 2006 Jan 5.

11.

Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study.

Sika M, Lewis J, Douglas J, Erlinger T, Dowie D, Lipkowitz M, Lash J, Cornish-Zirker D, Peterson G, Toto R, Kusek J, Appel L, Kendrick C, Gassman J; AASK group.

Am J Kidney Dis. 2007 Jul;50(1):78-89, 89.e1.

PMID:
17591527
12.

Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study.

Shen J, Arnett DK, Parnell LD, Peacock JM, Lai CQ, Hixson JE, Tsai MY, Province MA, Straka RJ, Ordovas JM.

Diabetes Care. 2008 May;31(5):910-5. doi: 10.2337/dc07-1687. Epub 2008 Feb 19.

13.

The rationale and design of the AASK cohort study.

Appel LJ, Middleton J, Miller ER 3rd, Lipkowitz M, Norris K, Agodoa LY, Bakris G, Douglas JG, Charleston J, Gassman J, Greene T, Jamerson K, Kusek JW, Lewis JA, Phillips RA, Rostand SG, Wright JT.

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S166-72.

14.

Influence of single-nucleotide polymorphisms on C-reactive protein levels in chronic kidney disease before and after kidney transplantation.

Cordeiro AC, de Castro I, Pecoits-Filho R, Ramasawmy R, Rodrigues H, Borba SC, Pereira LM, Romão JE Jr, David-Neto E, Ianhez LE, Kalil J, Abensur H.

Transplant Proc. 2008 Dec;40(10):3349-53. doi: 10.1016/j.transproceed.2008.04.021.

PMID:
19100387
15.

Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study.

Almeida OP, Norman PE, Allcock R, van Bockxmeer F, Hankey GJ, Jamrozik K, Flicker L.

Int J Epidemiol. 2009 Aug;38(4):1049-59. doi: 10.1093/ije/dyp199. Epub 2009 May 11.

16.

Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.

Weinberg JM, Appel LJ, Bakris G, Gassman JJ, Greene T, Kendrick CA, Wang X, Lash J, Lewis JA, Pogue V, Thornley-Brown D, Phillips RA; African American Study of Hypertension and Kidney Disease Collaborative Research Group.

Arch Intern Med. 2009 Sep 28;169(17):1587-94. doi: 10.1001/archinternmed.2009.284.

PMID:
19786678
17.

The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.

Fox ER, Benjamin EJ, Sarpong DF, Nagarajarao H, Taylor JK, Steffes MW, Salahudeen AK, Flessner MF, Akylbekova EL, Fox CS, Garrison RJ, Taylor HA Jr.

BMC Nephrol. 2010 Jan 15;11:1. doi: 10.1186/1471-2369-11-1.

18.

Quality of life and outcomes in African Americans with CKD.

Porter A, Fischer MJ, Wang X, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner M, Gassman J, Hiremath L, Kendrick C, Kusek JW, Norris KC, Thornley-Brown D, Greene T, Lash JP; AASK Study Group.

J Am Soc Nephrol. 2014 Aug;25(8):1849-55. doi: 10.1681/ASN.2013080835. Epub 2014 Apr 3.

19.

Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.

Nimptsch K, Aleksandrova K, Boeing H, Janke J, Lee YA, Jenab M, Bueno-de-Mesquita HB, Jansen EH, Tsilidis KK, Trichopoulou A, Weiderpass E, Wu C, Overvad K, Tjønneland A, Boutron-Ruault MC, Dossus L, Racine A, Kaaks R, Canzian F, Lagiou P, Trichopoulos D, Palli D, Agnoli C, Tumino R, Vineis P, Panico S, Johansson A, Van Guelpen B, Khaw KT, Wareham N, Peeters PH, Quirós JR, Venceslá García A, Molina-Montes E, Dorronsoro M, Chirlaque MD, Barricarte Gurrea A, Key TJ, Duarte-Salles T, Stepien M, Gunter MJ, Riboli E, Pischon T.

Int J Cancer. 2015 Mar 1;136(5):1181-92. doi: 10.1002/ijc.29086. Epub 2014 Jul 28.

20.

Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.

Chen TK, Choi MJ, Kao WH, Astor BC, Scialla JJ, Appel LJ, Li L, Lipkowitz MS, Wolf M, Parekh RS, Winkler CA, Estrella MM, Crews DC.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2128-35. doi: 10.2215/CJN.05220515. Epub 2015 Oct 1.

PMID:
26430087
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk